We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Robotic Platform Enables More Accurate Diagnosis of Cancer Cells

By LabMedica International staff writers
Posted on 25 Oct 2023
Print article
Image: A tissue sample, for example a lymph node, is only 5–10 mm in size (Photo courtesy of ETH Zurich)
Image: A tissue sample, for example a lymph node, is only 5–10 mm in size (Photo courtesy of ETH Zurich)

For more than a century, the field of histology, which falls under pathology and focuses on changes in tissue, has relied on an old-school method. This involves slicing tissue samples into extremely thin sections—each about seven times thinner than a human hair—and then examining them for any abnormal changes under a microscope. The downside of this traditional technique is that it leads to misdiagnosis in about one out of every six people, often missing cancer cells. Now, scientists have integrated biomedical technology with mechanical engineering to create a robotic system that not only diagnoses cancer more precisely but also offers three-dimensional insights into the spatial arrangement of cells.

Researchers from ETH Zurich (Zurich, Switzerland) and the University of Zurich (Zurich, Switzerland) are working on this robotic platform designed to improve the accuracy of cancer diagnosis by rapidly quantifying tissue samples in their entirety. The procedure involves four stages. First, the tissue sample is automatically made transparent. Second, any unusual cells are quickly stained or colored. The third phase consists of generating a 3D image that maps out the cancer cells; the technology for this is already available. The last phase involves analyzing the tissue using 3D imaging software and training algorithms. This novel approach eliminates the need for labor-intensive preparation and slicing of tissue samples; instead, the entire tissue sample—like a lymph node—is preserved and fully examined. The 3D digital images showing the marked cells can be accessed online whenever needed.

Currently, the robot prototype is functional in the lab and can maneuver samples as required. However, it's not yet completely market-ready. While the team can provide preliminary services like automatically rendering sent-in tissue samples transparent and generating labeled 3D images swiftly, the software still needs fine-tuning. The researchers aim to commercialize this robotic system, offering research laboratories and healthcare facilities a dependable and effective tool that could revolutionize the way cancer diagnosis is conducted in the digital age.

Related Links:
ETH Zurich 
University of Zurich 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.